期刊文献+

间充质干细胞治疗肝硬化的研究进展

下载PDF
导出
摘要 间充质干细胞(Mesenchymal stem cells,MSC),已经成为以干细胞为基础治疗肝脏疾病的最具吸引力的工具。通过各种不同的机制,促进肝脏功能恢复。MSC能够分化成有功能的肝细胞,也能产生一系列生长因子和细胞因子,抑制炎症反应,减少肝细胞凋亡,抑制星状细胞活化,降低肝纤维化,调节免疫。
出处 《现代消化及介入诊疗》 2012年第5期303-305,共3页 Modern Interventional Diagnosis and Treatment in Gastroenterology
  • 相关文献

参考文献7

  • 1Pan RL, Wang P, Xiang LX, et al. Delta-like 1 serves as a new tar- get and contributor to liver fibrosis down-regulated by mesenchy- real stem cell transplantation. J Biol Chem, 2011,286(14):12340- 12348.
  • 2Yoshiji H, Kuriyama S, Yoshii J, et al. Tissue inhibitor of metallo- proteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology, 2002,36(4 Ptl):850-860.
  • 3Lazarus H, Curtin P, Devine S, et al. Role of mesenchymalstem cells (MSC) in allogeneictransplarttation: Early phasel clinical results. Blood, 2000,96:392-396.
  • 4Augello A, Tasso R, Negrini SM, et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol, 2005,35:1482-1490.
  • 5Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem ceils modulate B-cell functions. Blood, 2006,107:367-372.
  • 6Colletti E, Airey JA, Liu W, et al. Generation of tissue-speci?c ceils by MSC does not require fusion or donor to host mitochondrial/ membrane transfer. Stem Cell, 2009,2:125-138.
  • 7Mehdi Mohamadnejad,Mehrnaz Namiri,Mohamad Bagheri,Seyed Masiha Hashemi,Hossein Ghanaati,Narges Zare Mehrjardi,Saeed Kazemi Ashtiani,Reza Malekzadeh,Hossein Baharvand.Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis[J].World Journal of Gastroenterology,2007,13(24):3359-3363. 被引量:74

二级参考文献21

  • 1[1]Ganji A,Safavi M,Nouraie SM,Nasseri-Moghadam S,Merat Sh,Vahedi H,Malekzadeh R.Digestive and liver diseases statistics in several referral centers in Tehran,2000-2004.Govaresh 2006; 11:33-38
  • 2[2]Malek-Hosseini SA,Mehdizadeh AR,Salahi H,Saberi-Firouzi M,Bagheri-Lankarani K,Bahador A,Imanieh MH,Nik-Eghbalian S,Lahsaee M,Khosravi MB,Arasteh MM,Bagheri MH,Geramizadeh B,Razmkon A,Tabei SZ.Results of liver transplantation:analysis of 140 cases at a single center.Transplant Proc 2005; 37:3157-3158
  • 3[3]Sakaida I,Terai S,Nishina H,Okita K.Development of cell therapy using autologous bone marrow cells for liver cirrhosis.Med Mol Morphol 2005; 38:197-202
  • 4[4]Schachinger V,Erbs S,Elsasser A,Haberbosch W,Hambrecht R,Holschermann H,Yu J,Corti R,Mathey DG,Hamm CW,Suselbeck T,Assmus B,Tonn T,Dimmeler S,Zeiher AM.Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.N Engl J Med 2006; 355:1210-1221
  • 5[5]Almeida-Porada G,Porada CD,Chamberlain J,Torabi A,Zanjani ED.Formation of human hepatocytes by human hematopoietic stem cells in sheep.Blood 2004; 104:2582-2590
  • 6[6]Sakaida I,Terai S,Yamamoto N,Aoyama K,Ishikawa T,Nishina H,Okita K.Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.Hepatology 2004;40:1304-1311
  • 7[7]am Esch JS 2nd,Knoefel WT,Klein M,Ghodsizad A,Fuerst G,Poll LW,Piechaczek C,Burchardt ER,Feifel N,Stoldt V,Stockschlader M,Stoecklein N,Tustas RY,Eisenberger CF,Peiper M,Haussinger D,Hosch SB.Portal application of autologous CD133+ bone marrow cells to the liver:a novel concept to support hepatic regeneration.Stem Cells 2005; 23:463-470
  • 8[8]Montazeri A,Goshtasebi A,Vahdaninia M,Gandek B.The Short Form Health Survey (SF-36):translation and validation study of the Iranian version.Qual Life Res 2005; 14:875-882
  • 9[9]Mohyeddin Bonab M,Yazdanbakhsh S,Alimoghaddam K,Talebian F,Hooshmand F,Lotfi J,Ghavamzadeh A.Mesenchymal stem cell therapy for multiple sclerosis.Int J Hematol Oncol BMT 2005; 2:10-16
  • 10[10]Snyder EY,Daley GQ,Goodell M.Taking stock and planning for the next decade:realistic prospects for stem cell therapies for the nervous system.J Neurosci Res 2004; 76:157-168

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部